BioCentury
ARTICLE | Company News

Inovio, Roche deal

August 8, 2016 7:00 AM UTC

Inovio said Roche is terminating a 2013 deal and returning exclusive, worldwide rights to Inovio’s INO-1800. Roche said the termination was a “strategic decision” and that the pharma will pay Inovio ...